Insider filing · ANIP
Nikhil Lalwani
PRESIDENT & CEO
profile →
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · 47 filings in 24 months
ticker →
Nikhil Lalwani sold $4.3M of ANI Pharmaceuticals (ANIP)
Executed May 11, disclosed May 13, 2 days later.
Value, as filed
$4.3M
55,000 sh × $77.57
Executed
May 11
the trade date, as filed
Disclosed
May 13
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NLNikhil Lalwani (PRESIDENT & CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $4.3M of ANIP (55,000 sh × $77.57, as filed), executed May 11.
The name
ANIPHealthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Nikhil Lalwani in ANIP
ANIPSALE
ANI Pharmaceuticals, Inc.
$383K5,400 sh × $71.00
Exec Sep 15
Filed Sep 16 · 4:20 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $401K
5,400 sh × $74.30
Exec Aug 25
Filed Aug 26 · 6:15 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $4.9M
56,960 sh × $85.93
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $1.9M
33,481 sh across 2 lots
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET